Home
Team
Media
Partners
Careers
Contact
Home
Team
Media
Partners
Careers
Contact
Featured
Sep 19, 2023
Keynote Panel @ RNA Leaders USA Congress
Sep 19, 2023
Sep 19, 2023
Apr 15, 2023
Op-Ed in BioCentury: The urgent need for variant-proof therapeutics
Apr 15, 2023
Apr 15, 2023
Apr 15, 2023
Autonomous Therapeutics, CEO, Dr. Ariel Weinberger interviewed by Vaccine Nation about next-generation mRNA therapeutics and antivirals
Apr 15, 2023
Apr 15, 2023
Nov 21, 2021
Autonomous CEO, Dr. Ariel Weinberger, presents on novel mRNA therapeutic technologies at the World Antiviral Congress
Nov 21, 2021
Nov 21, 2021
Jan 19, 2021
BioBuzz Interviews Autonomous Therapeutics CEO Ariel Weinberger
Jan 19, 2021
Jan 19, 2021
Oct 19, 2020
Antiviral drug company working on Covid-19 relocates to Rockville
Oct 19, 2020
Oct 19, 2020
Oct 1, 2020
Autonomous Therapeutics chosen by BARDA to present at 2020 BARDA Industry Day
Oct 1, 2020
Oct 1, 2020
Aug 27, 2020
Autonomous Therapeutics selected for BLUE KNIGHT, a joint initiative between BARDA (a component of the U.S. Department of Health and Human Services) and Johnson & Johnson Innovation – JLABS
Aug 27, 2020
Aug 27, 2020
Feb 19, 2019
DARPA selects Autonomous Therapeutics to support PREventing EMerging Pathogenic Threats (PREEMPT) initiative
Feb 19, 2019
Feb 19, 2019